Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Mountz

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Journal of Nuclear Medicine Technology|July 26, 2020
<sup>18</sup>F-FDG PET/MRI Primary Staging of Cervical Cancer: A Pilot Study with PET/CT ComparisonNghi C Nguyen, Sushil Beriwal, Chan-Hong Moon, et al.
Arthritis and Rheumatism|August 31, 2004
Positron emission tomography in patients with fibromyalgia syndrome and healthy controlsMuhammad B Yunus, Carter S Young, S Atezaz Saeed, et al.
The Annals of Thoracic Surgery|September 1, 2004
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancerRobert James Cerfolio, Buddhiwardhani Ojha, Ayesha S Bryant, et al.
Tomography (Ann Arbor, Mich.)|July 26, 2018
[<sup>18</sup>F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response AssessmentMatthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 16, 2010
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progressionFarzin Imani, Fernando E Boada, Frank S Lieberman, et al.
Frontiers in Oncology|March 10, 2018
Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot StudyNghi C Nguyen, Melissa K Yee, Abuzar M Tuchayi, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Molecular imaging: new applications for biochemistryJohn D Mountz, Hui-Chen Hsu, Qi Wu, et al.
The Annals of Thoracic Surgery|September 10, 2003
The role of FDG-PET scan in staging patients with nonsmall cell carcinomaRobert J Cerfolio, Buddhiwardhan Ojha, Ayesha S Bryant, et al.
Translational Oncology|April 29, 2014
Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10Matthew J Oborski, Charles M Laymon, Yongxian Qian, et al.
Brain and Behavior|April 1, 2014
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapyMatthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Journal of Nuclear Medicine Technology|July 26, 2020
<sup>18</sup>F-FDG PET/MRI Primary Staging of Cervical Cancer: A Pilot Study with PET/CT ComparisonNghi C Nguyen, Sushil Beriwal, Chan-Hong Moon, et al.
Arthritis and Rheumatism|August 31, 2004
Positron emission tomography in patients with fibromyalgia syndrome and healthy controlsMuhammad B Yunus, Carter S Young, S Atezaz Saeed, et al.
The Annals of Thoracic Surgery|September 1, 2004
The accuracy of integrated PET-CT compared with dedicated PET alone for the staging of patients with nonsmall cell lung cancerRobert James Cerfolio, Buddhiwardhani Ojha, Ayesha S Bryant, et al.
Tomography (Ann Arbor, Mich.)|July 26, 2018
[<sup>18</sup>F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response AssessmentMatthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|December 16, 2010
Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progressionFarzin Imani, Fernando E Boada, Frank S Lieberman, et al.
Frontiers in Oncology|March 10, 2018
Targeted Therapy and Immunotherapy Response Assessment with F-18 Fluorothymidine Positron-Emission Tomography/Magnetic Resonance Imaging in Melanoma Brain Metastasis: A Pilot StudyNghi C Nguyen, Melissa K Yee, Abuzar M Tuchayi, et al.
Journal of Cellular Biochemistry. Supplement|January 29, 2003
Molecular imaging: new applications for biochemistryJohn D Mountz, Hui-Chen Hsu, Qi Wu, et al.
The Annals of Thoracic Surgery|September 10, 2003
The role of FDG-PET scan in staging patients with nonsmall cell carcinomaRobert J Cerfolio, Buddhiwardhan Ojha, Ayesha S Bryant, et al.
Translational Oncology|April 29, 2014
Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10Matthew J Oborski, Charles M Laymon, Yongxian Qian, et al.
Brain and Behavior|April 1, 2014
First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapyMatthew J Oborski, Charles M Laymon, Frank S Lieberman, et al.
Pageof 9